NPI: 1205283538 · VERNON, CT 06066 · Emergency Care Clinic/Center · NPI assigned 05/17/2016
Authorized official ELDERS, ROBERT controls 20+ related entities in our dataset. Read more
| Authorized Official | ELDERS, ROBERT (SECRETARY) |
| NPI Enumeration Date | 05/17/2016 |
Other providers sharing the same authorized official: ELDERS, ROBERT
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 119,694 | $4.28M |
| 2019 | 117,561 | $4.70M |
| 2020 | 94,434 | $3.45M |
| 2021 | 115,256 | $4.31M |
| 2022 | 123,670 | $4.96M |
| 2023 | 104,229 | $4.26M |
| 2024 | 96,548 | $4.10M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| G0384 | Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 10,368 | 8,970 | $6.35M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9,728 | 8,406 | $3.34M |
| G0383 | Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 9,196 | 8,177 | $2.07M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 7,983 | 6,987 | $1.94M |
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 10,679 | 9,688 | $1.88M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 11,747 | 10,018 | $1.81M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 9,386 | 8,239 | $1.65M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 12,265 | 9,279 | $1.17M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4,325 | 3,992 | $1.03M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 23,236 | 7,055 | $699K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 14,820 | 4,923 | $570K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 4,707 | 4,623 | $545K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 873 | 807 | $534K |
| 96375 | Therapeutic injection; each additional sequential IV push | 9,023 | 7,399 | $486K |
| 70450 | Computed tomography, head or brain; without contrast material | 4,749 | 4,318 | $476K |
| 96361 | Intravenous infusion, hydration; each additional hour | 7,906 | 6,574 | $439K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 10,587 | 9,633 | $414K |
| 71046 | Radiologic examination, chest; 2 views | 7,972 | 7,181 | $412K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,608 | 2,349 | $357K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2,011 | 1,824 | $272K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,785 | 1,666 | $262K |
| 71045 | Radiologic examination, chest; single view | 5,121 | 4,563 | $255K |
| 97010 | 12,702 | 4,370 | $189K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 4,052 | 1,782 | $177K |
| G0381 | Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 1,700 | 1,621 | $170K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,518 | 1,403 | $170K |
| 77065 | Tomosynthesis, mammo | 1,217 | 1,136 | $122K |
| 97161 | 1,983 | 1,890 | $120K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 269 | 249 | $117K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1,140 | 1,100 | $116K |
| 76642 | 1,712 | 1,503 | $95K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 985 | 923 | $94K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1,474 | 1,332 | $92K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1,023 | 957 | $88K |
| 76641 | 1,464 | 891 | $84K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2,729 | 1,261 | $81K |
| 97162 | 1,327 | 1,259 | $73K | |
| 93971 | 940 | 874 | $63K | |
| G0380 | Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 932 | 869 | $62K |
| 97535 | Self-care/home management training, each 15 minutes | 2,450 | 1,735 | $62K |
| 97014 | 4,011 | 1,822 | $61K | |
| 97035 | 3,740 | 1,568 | $61K | |
| 76830 | Ultrasound, transvaginal | 680 | 624 | $58K |
| 82947 | 23,194 | 19,666 | $57K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 506 | 463 | $55K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 68 | 65 | $51K |
| 90834 | Psychotherapy, 45 minutes with patient | 953 | 567 | $47K |
| 71250 | 878 | 845 | $47K | |
| 73564 | 1,743 | 1,462 | $44K | |
| 73610 | 1,939 | 1,711 | $43K | |
| 72100 | 1,483 | 1,427 | $41K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 457 | 444 | $39K |
| 73030 | 1,995 | 1,762 | $35K | |
| 73630 | 2,012 | 1,783 | $29K | |
| 97012 | 507 | 209 | $28K | |
| 73130 | 1,632 | 1,372 | $28K | |
| 77080 | 289 | 281 | $27K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 114 | 106 | $24K |
| 73110 | 1,087 | 918 | $23K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7,472 | 6,738 | $23K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,279 | 1,173 | $23K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 322 | 309 | $21K |
| 97113 | 382 | 162 | $19K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 448 | 392 | $15K |
| G0378 | Hospital observation service, per hour | 3,343 | 2,749 | $15K |
| 77066 | Tomosynthesis, mammo | 137 | 134 | $14K |
| 73502 | 1,059 | 997 | $14K | |
| 0012A | 362 | 354 | $13K | |
| 0011A | 425 | 366 | $13K | |
| 76536 | 150 | 146 | $11K | |
| 73562 | 977 | 798 | $10K | |
| 73140 | 389 | 338 | $10K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 849 | 779 | $9K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 849 | 779 | $9K |
| 70486 | 154 | 147 | $7K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 25 | 21 | $7K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 40 | 39 | $6K |
| 72110 | 97 | 96 | $6K | |
| 36415 | Collection of venous blood by venipuncture | 42,077 | 22,174 | $6K |
| 97165 | 85 | 76 | $5K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 63 | 57 | $5K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 11,825 | 10,290 | $5K |
| 76801 | 41 | 38 | $4K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 23,893 | 19,939 | $4K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5,097 | 4,392 | $4K |
| 74018 | 157 | 143 | $4K | |
| 80051 | 23,769 | 19,901 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2,201 | 2,017 | $3K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 55 | 46 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3,464 | 2,577 | $3K |
| 97032 | 100 | 55 | $2K | |
| 80053 | Comprehensive metabolic panel | 737 | 633 | $2K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 1,146 | 901 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 5,516 | 4,370 | $2K |
| 93970 | 12 | 12 | $2K | |
| 82565 | 23,917 | 20,018 | $2K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 13 | 12 | $2K |
| 72072 | 39 | 39 | $2K | |
| 99215 | Prolong outpt/office vis | 19 | 12 | $2K |
| 85610 | 3,780 | 3,059 | $2K | |
| J3490 | Unclassified drugs | 35,612 | 15,989 | $1K |
| 80061 | Lipid panel | 123 | 117 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,664 | 1,160 | $1K |
| 73080 | 57 | 51 | $960.90 | |
| 81025 | 8,821 | 7,823 | $892.97 | |
| 72040 | 40 | 39 | $870.12 | |
| 96367 | 14 | 13 | $786.65 | |
| 83735 | 6,735 | 5,857 | $750.39 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 71 | 15 | $706.05 |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 164 | 158 | $622.51 |
| 84520 | 23,812 | 19,936 | $592.35 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 462 | 332 | $575.75 |
| 0002A | 54 | 30 | $538.97 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,142 | 3,727 | $538.57 |
| 85027 | 1,972 | 1,696 | $524.16 | |
| 83880 | 2,670 | 2,400 | $513.56 | |
| 84484 | 7,926 | 6,723 | $494.77 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,325 | 2,181 | $456.76 |
| 71101 | 24 | 24 | $395.43 | |
| 87070 | 2,388 | 2,200 | $382.54 | |
| 77061 | 133 | 127 | $360.80 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2,870 | 2,658 | $336.84 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 15 | 12 | $332.97 |
| 93017 | 12 | 12 | $331.74 | |
| 82553 | 544 | 421 | $295.97 | |
| 83690 | 9,525 | 8,250 | $295.87 | |
| 81001 | 7,847 | 6,976 | $257.39 | |
| 82247 | 17,951 | 15,399 | $256.81 | |
| 0001A | 45 | 30 | $252.99 | |
| 87186 | 1,573 | 1,430 | $242.31 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 97 | 89 | $240.11 |
| 85007 | 1,489 | 1,258 | $221.82 | |
| 82040 | 17,980 | 15,395 | $214.23 | |
| 84450 | 18,075 | 15,466 | $212.28 | |
| 81002 | 12,273 | 10,494 | $212.08 | |
| 84075 | 17,948 | 15,397 | $204.02 | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 198 | 195 | $198.50 |
| 85379 | 2,341 | 2,146 | $190.68 | |
| 73090 | 12 | 12 | $182.18 | |
| 84460 | 18,083 | 15,475 | $182.10 | |
| 73590 | 14 | 14 | $181.06 | |
| 84155 | 17,961 | 15,387 | $152.87 | |
| 86900 | 936 | 826 | $146.65 | |
| 94761 | 2,451 | 2,179 | $144.05 | |
| 86885 | 61 | 52 | $137.31 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 7,002 | 5,366 | $133.42 |
| 83605 | 2,764 | 2,419 | $111.37 | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 26 | 25 | $110.00 |
| 84702 | 561 | 498 | $106.65 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 6,565 | 6,025 | $105.17 |
| 85730 | 573 | 505 | $105.03 | |
| 90714 | 594 | 555 | $101.99 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 65 | 29 | $101.12 |
| 82728 | 158 | 141 | $94.34 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 7,458 | 6,371 | $90.09 |
| 86140 | 397 | 333 | $87.64 | |
| 96376 | 2,769 | 2,104 | $84.59 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 203 | 184 | $83.23 |
| 82310 | 3,091 | 2,802 | $79.03 | |
| 82948 | 2,873 | 2,172 | $75.03 | |
| 87040 | 1,634 | 1,467 | $74.35 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 882 | 801 | $71.30 |
| 87077 | 393 | 351 | $66.22 | |
| 84145 | 507 | 457 | $61.82 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 733 | 600 | $55.57 |
| 87205 | 367 | 318 | $52.91 | |
| 84100 | 793 | 692 | $50.60 | |
| 85652 | 141 | 123 | $49.79 | |
| 86901 | 936 | 826 | $47.49 | |
| 82550 | 261 | 227 | $37.56 | |
| 91300 | 82 | 42 | $33.33 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 9,567 | 7,627 | $31.58 |
| J1170 | Injection, hydromorphone, up to 4 mg | 4,447 | 2,046 | $28.18 |
| 87420 | 525 | 481 | $24.54 | |
| 36416 | 2,878 | 2,162 | $20.11 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 908 | 826 | $19.69 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 1,421 | 1,232 | $18.72 |
| 86618 | 82 | 80 | $16.27 | |
| 82140 | 28 | 24 | $13.92 | |
| 80164 | 13 | 12 | $12.94 | |
| 80076 | 25 | 24 | $12.91 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 273 | 219 | $10.54 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 3,168 | 2,195 | $9.74 |
| 86403 | 116 | 106 | $9.73 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,233 | 1,067 | $9.32 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,318 | 1,567 | $5.12 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 618 | 382 | $4.05 |
| 94760 | 914 | 779 | $3.51 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 346 | 286 | $3.22 |
| J2060 | Injection, lorazepam, 2 mg | 2,535 | 1,776 | $3.19 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,477 | 1,255 | $3.13 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 993 | 845 | $3.08 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 1,100 | 951 | $1.84 |
| A9150 | Non-prescription drugs | 1,232 | 972 | $1.66 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 285 | 220 | $1.31 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 210 | 172 | $1.10 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 30 | 25 | $0.11 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 189 | 176 | $0.00 |
| 88313 | 284 | 257 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 543 | 477 | $0.00 |
| 82075 | 274 | 232 | $0.00 | |
| 82800 | 14 | 13 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 85 | 75 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 143 | 88 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 117 | 41 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 42 | 40 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 123 | 51 | $0.00 |
| 77062 | 26 | 26 | $0.00 | |
| Q0243 | Injection, casirivimab and imdevimab, 2400 mg | 36 | 32 | $0.00 |
| 93041 | 134 | 106 | $0.00 | |
| 88342 | 327 | 294 | $0.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | 341 | 265 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 123 | 101 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 2,466 | 2,424 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 1,545 | 1,229 | $0.00 |
| A9270 | Non-covered item or service | 178 | 151 | $0.00 |
| 83615 | 95 | 84 | $0.00 | |
| 84703 | 100 | 96 | $0.00 | |
| 12001 | 66 | 64 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 38 | 31 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 48 | 28 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 252 | 220 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 97 | 83 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 57 | 37 | $0.00 |
| 91301 | 782 | 677 | $0.00 | |
| A9585 | Injection, gadobutrol, 0.1 ml | 13 | 13 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 13 | 12 | $0.00 |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16 | 15 | $0.00 |